S-Network Biopharma M&A Index

An index of mid to large cap biotechnology and pharmaceutical stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials or year on year sales growth. 

As January 25, 2023 Index Level 3-Month 6-Month 1-Year YTD
Price Return 6,336.6 15.7% 13.4% 7.6% 8.2%
Total Return 6,785.4 15.8% 13.5% 7.8% 8.2%
Net Total Return 6,665.6 15.8% 13.5% 7.8% 8.2%
Index Level 6,336.6
3-Month 15.7%
6-Month 13.4%
1-Year 7.6%
YTD 8.2%
Index Level 6,785.4
3-Month 15.8%
6-Month 13.5%
1-Year 7.8%
YTD 8.2%
Index Level 6,665.6
3-Month 15.8%
6-Month 13.5%
1-Year 7.8%
YTD 8.2%

As of January 25, 2023

Characteristics

Index Symbol (Price Return) PBMA
Index Symbol (Total Return) PBMATR
Index Symbol (Net Total Return) PBMANTR
Number of Constituents 137
Market Capitalization $627 Billion
Adjusted Market Capitalization $115 Million
Rebalancings Quarterly
Dividend Yield 0.1%

Composition

Top Index Constituents
As of February 6, 2023

Interested in Market Data packages?

VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.

Contact Us